Autophagic regulation of inflammasome-mediated hyperactive state in living macrophages
活体巨噬细胞中炎症小体介导的过度活跃状态的自噬调节
基本信息
- 批准号:10732307
- 负责人:
- 金额:$ 8.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-12 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAntibodiesAutophagocytosisBindingBiologicalBiological AssayCASP1 geneCalibrationCaspaseCell DeathCell membraneCellsColitisComplexCoupledGenesHematopoieticHost DefenseHyperactivityIL18 geneImmune responseInflammasomeInflammationInflammatoryInjectionsInterleukinsLeucine-Rich RepeatLinkLyticMacrophageMediatingMusNucleotidesPeptide HydrolasesPhenotypePredispositionProcessProteinsPublishingRegulationReportingRoleScienceSignal TransductionSodium Dextran SulfateYincellular imagingcytokinehuman diseasepathogenresponse
项目摘要
Abstract
Nucleotide-binding domain (NBD) and leucine-rich repeat (LRR)-containing proteins (NLRs) assemble into
functional supramolecular organizing centers called the inflammasomes, which serve as an interface of host
defense against pathogens or other types of danger. Canonical inflammasomes activate caspase-1, an
inflammatory protease that upon activation, triggers two important biological responses: 1) processing of cytokine
interleukin-1b (IL-1b), and 2) formation of plasma membrane gasdermin D pores to potentiate inflammatory cell
death (pyroptosis). Cytokine secretion and pyroptosis are coupled under a steady-state condition, as the GSDMD
pores on the plasma membrane, which permeates IL-1b, can also compromise the cell membrane integrity
leading to the lytic cell death. Interestingly, in a hyperactive state following inflammasome activation, cells show
sustained cytokine secretion but retain viability, even though this process is dependent on GSDMD pores formed
on the plasma membrane. The underlying mechanisms which recalibrate GSDMD to only sustain the release of
the interleukin, but not pyroptosis, are poorly understood.
Autophagy is regarded as an important regulator of inflammation. In our recent studies, we found that
inflammasomes are regulated by an aggresome-like mechanism that promotes inflammasome assembly (Yang)
but also induces autophagy to dampen caspase-1 processing and IL-b secretion (Yin) (Magupalli et al., Science,
2020). Our studies are consistent with previous reports showing that mice lacking the key autophagic gene,
Atg16L1, in hematopoietic cells, were highly susceptible to dextran sulphate sodium-induced acute colitis, with
the secretion of a high amount of IL-1b
and IL-18 cytokines. In addition, these
inflammatory phenotypes were
alleviated by injection of anti-IL-1b and IL-18 antibodies in mice. Collectively, our and other published results
demonstrate that autophagy directly regulates the extent to which inflammasomes activate downstream signals.
However, it is unclear if autophagy can regulate the switch between a hyperactive state and a pyroptotic state of
macrophages.
In this application, we will investigate the potential link between autophagy and macrophage
hyperactivation using inflammasome assays and cellular imaging.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Venkat Giri Magupalli其他文献
SMOCs: supramolecular organizing centres that control innate immunity
SMOCs:控制先天免疫的超分子组织中心
- DOI:
10.1038/nri3757 - 发表时间:
2014-10-31 - 期刊:
- 影响因子:60.900
- 作者:
Jonathan C. Kagan;Venkat Giri Magupalli;Hao Wu - 通讯作者:
Hao Wu
Venkat Giri Magupalli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Venkat Giri Magupalli', 18)}}的其他基金
Autophagic regulation of inflammasome-mediated hyperactive state in living macrophages
活体巨噬细胞中炎症小体介导的过度活跃状态的自噬调节
- 批准号:
10449254 - 财政年份:2021
- 资助金额:
$ 8.54万 - 项目类别:
Autophagic regulation of inflammasome-mediated hyperactive state in living macrophages
活体巨噬细胞中炎症小体介导的过度活跃状态的自噬调节
- 批准号:
10288904 - 财政年份:2021
- 资助金额:
$ 8.54万 - 项目类别:
Autophagic regulation of inflammasome-mediated hyperactive state in living macrophages
活体巨噬细胞中炎症小体介导的过度活跃状态的自噬调节
- 批准号:
10755554 - 财政年份:2021
- 资助金额:
$ 8.54万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 8.54万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 8.54万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 8.54万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 8.54万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 8.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 8.54万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 8.54万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 8.54万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 8.54万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 8.54万 - 项目类别: